Ed Addison is the CEO and co-founder of Perlara, a biotech company that focuses on using model organisms and AI to discover potential drug candidates for rare genetic diseases. Perlara's unique approach involves leveraging the power of model organisms, such as yeast and worms, to identify and validate therapeutic targets.